Literature DB >> 26105620

Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

R A A Pondé1.   

Abstract

Although genomic detection is considered the gold standard test on HBV infection identification, the HBsAg investigation is still the most frequent clinical laboratory request to diagnose HBV infection in activity. However, the non-detection of HBsAg in the bloodstream of chronic or acutely infected individuals has been a phenomenon often observed in clinical practice, despite the high sensitivity and specificity of screening assays standardized commercially and adopted in routine. The expansion of knowledge about the hepatitis B virus biology (replication/life cycle, genetic variability/mutability/heterogeneity), their biochemical and immunological properties (antigenicity and immunogenicity), in turn, has allowed to elucidate some mechanisms that may explain the occurrence of this phenomenon. Therefore, the negativity for HBsAg during the acute or chronic infection course may become a fragile or at least questionable result. This manuscript discusses some mechanisms that could explain the negativity for HBsAg in a serological profile of individuals with HBV infection in activity, or factors that could compromise its detection in the bloodstream during HBV infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26105620     DOI: 10.1007/s10096-015-2422-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  217 in total

1.  Standardized detection of hepatitis B surface antigen: determination of its serum concentration in weight units per volume.

Authors:  W Gerlich; R Thomssen
Journal:  Dev Biol Stand       Date:  1975

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Fatal HBV reactivation in a subject with anti-HBs and anti-HBc.

Authors:  Takeji Umemura; Kendo Kiyosawa
Journal:  Intern Med       Date:  2006-07-18       Impact factor: 1.271

4.  Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?

Authors:  Susan L Stramer; Shimian Zou; Edward P Notari; Gregory A Foster; David E Krysztof; Fatemeh Musavi; Roger Y Dodd
Journal:  Transfusion       Date:  2011-08-02       Impact factor: 3.157

Review 5.  Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication.

Authors:  Yoshiaki Mizuguchi; Toshihiro Takizawa; Eiji Uchida
Journal:  World J Hepatol       Date:  2015-04-08

6.  Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter.

Authors:  Vaishali Chaudhuri; Ruchi Tayal; Baibaswata Nayak; Subrat Kumar Acharya; Subrat Kumar Panda
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 7.  HBsAg variants: diagnostic-escape and diagnostic dilemma.

Authors:  Seyed Moayed Alavian; William F Carman; Seyed Mohammad Jazayeri
Journal:  J Clin Virol       Date:  2012-07-11       Impact factor: 3.168

Review 8.  The core promoter of hepatitis B virus.

Authors:  A Kramvis; M C Kew
Journal:  J Viral Hepat       Date:  1999-11       Impact factor: 3.728

9.  Enhancement of hepatitis B virus replication by its X protein in transgenic mice.

Authors:  Zhenming Xu; T S Benedict Yen; Lanying Wu; Charles R Madden; Wenjie Tan; Betty L Slagle; Jing-hsiung Ou
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

10.  Mutations of some critical amino acid residues in the hepatitis B virus surface antigen.

Authors:  S A Bruce; K Murray
Journal:  J Med Virol       Date:  1995-06       Impact factor: 2.327

View more
  10 in total

Review 1.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

2.  Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia.

Authors:  Julio Cesar Rendon; Fabian Cortes-Mancera; Juan Carlos Restrepo-Gutierrez; Sergio Hoyos; Maria-Cristina Navas
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

3.  Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt.

Authors:  Abeer Elkady; Sayuki Iijima; Sahar Aboulfotuh; Elsayed Mostafa Ali; Douaa Sayed; Nashwa M Abdel-Aziz; Amany M Ali; Shuko Murakami; Masanori Isogawa; Yasuhito Tanaka
Journal:  World J Hepatol       Date:  2017-03-28

4.  Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Authors:  Luna Colagrossi; Lucas E Hermans; Romina Salpini; Domenico Di Carlo; Suzan D Pas; Marta Alvarez; Ziv Ben-Ari; Greet Boland; Bianca Bruzzone; Nicola Coppola; Carole Seguin-Devaux; Tomasz Dyda; Federico Garcia; Rolf Kaiser; Sukran Köse; Henrik Krarup; Ivana Lazarevic; Maja M Lunar; Sarah Maylin; Valeria Micheli; Orna Mor; Simona Paraschiv; Dimitros Paraskevis; Mario Poljak; Elisabeth Puchhammer-Stöckl; François Simon; Maja Stanojevic; Kathrine Stene-Johansen; Nijaz Tihic; Pascale Trimoulet; Jens Verheyen; Adriana Vince; Snjezana Zidovec Lepej; Nina Weis; Tülay Yalcinkaya; Charles A B Boucher; Annemarie M J Wensing; Carlo F Perno; Valentina Svicher
Journal:  BMC Infect Dis       Date:  2018-06-01       Impact factor: 3.090

Review 5.  Viral Biomarkers in Chronic HBeAg Negative HBV Infection.

Authors:  Emilia Hadziyannis; Andreas Laras
Journal:  Genes (Basel)       Date:  2018-09-27       Impact factor: 4.096

6.  Prevalence, Risk Behaviors, and Virological Characteristics of Hepatitis B Virus Infection in a Group of Men Who Have Sex with Men in Brazil: Results from a Respondent-Driven Sampling Survey.

Authors:  Marina P Oliveira; Márcia A D Matos; Ágabo M C Silva; Carmen L R Lopes; Sheila A Teles; Marcos A Matos; Natália Spitz; Natalia M Araujo; Rosa M S Mota; Ligia R F S Kerr; Regina M B Martins
Journal:  PLoS One       Date:  2016-08-10       Impact factor: 3.240

7.  Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study.

Authors:  Yan Mardian; Yoshihiko Yano; Widya Wasityastuti; Neneng Ratnasari; Yujiao Liang; Wahyu Aristyaning Putri; Teguh Triyono; Yoshitake Hayashi
Journal:  Virol J       Date:  2017-10-23       Impact factor: 4.099

8.  Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers.

Authors:  Rajiv Kumar Mondal; Mousumi Khatun; Priyanka Banerjee; Alip Ghosh; Sumanta Sarkar; Amal Santra; Kausik Das; Abhijit Chowdhury; Soma Banerjee; Simanti Datta
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

9.  Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.

Authors:  Mary C Kuhns; Vera Holzmayer; Mark Anderson; Anne L McNamara; Silvia Sauleda; Dora Mbanya; Pham T Duong; Nguyen T T Dung; Gavin A Cloherty
Journal:  Viruses       Date:  2021-10-13       Impact factor: 5.048

10.  Detection of Q129H Immune Escape Mutation in Apparently Healthy Hepatitis B Virus Carriers in Southwestern Nigeria.

Authors:  Olufisayo Adeyemi Adesina; Olusola Anuoluwapo Akanbi; Oluyinka Oladele Opaleye; Margaret Oluwatoyin Japhet; Bo Wang; Adekemi Olubukunola Oluyege; Patrycja Klink; C-Thomas Bock
Journal:  Viruses       Date:  2021-06-29       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.